Dec 12
|
Contact lens maker Bausch + Lomb says it is exploring sale
|
Dec 12
|
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
|
Dec 12
|
Eye health company Bausch + Lomb’s affiliate acquires Elios Vision
|
Dec 11
|
TSX Closer: The Market Surges as the Bank of Canada Makes Its Jumbo Cut, Further Cuts Predicted
|
Dec 11
|
TSX up 105 Points at Midday, With Info Tech, Energy, Higher; Healthcare The Biggest Decliner
|
Dec 11
|
Bausch + Lomb down after report that Blackstone could back away from takeover bid
|
Dec 11
|
Market Chatter: Blackstone Withdraws From Bausch + Lomb Takeover Talks
|
Dec 11
|
Why Is Bausch Health Companies Inc. (BHC) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?
|
Sep 30
|
Investor Alert and Limitation Period: Canadian investors that purchased shares of Bausch Health Companies, Inc. listed on the Toronto Stock Exchange need to act
|
Sep 28
|
Bausch Health Companies Inc. (BHC): A Top Pick in Carl Icahn’s Stock Portfolio
|
Aug 20
|
Bausch Health Companies Inc. (BHC): One of the Best Canadian Stocks Under $20
|
Jul 25
|
Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?
|
Jul 24
|
Bausch Health Stock Swings Wildly as it Addresses Report It's Considering Bankruptcy
|
Jul 24
|
Bausch Health Responds to Market Rumors
|
Jul 24
|
Bausch Health tanks 23.3% on unconfirmed report of bankruptcy filing
|
Jul 24
|
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
|
Jul 23
|
Nanotechnology in medicine: Who are the leading public companies?
|
Jun 20
|
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
|
Jun 16
|
With 63% ownership of the shares, Bausch Health Companies Inc. (NYSE:BHC) is heavily dominated by institutional owners
|
Jun 14
|
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
|